pR∆DE•EMCVF and pR∆DE•HCVF, Dr. Peter Sarnow (Stanford University, Stanford, CA); pcDNA3-Flag-4B, Dr. John WB Hershey (University of California, Davis, CA) pSG5-eIF4AI was produced by insertion into the EcoRI and BamHI sites of pSG5 (Stratagene, La Jolla, CA) and pSG5-myc-STRAP included a myc tag at the N-terminus.
Biotin-conjugate pulldown:
RKO cells were grown to 50% confluency, harvested by Trypsin-EDTA treatment and washed once with PBS, then lysed using a dounce homogenizer in 5ml buffer (20 mM Tris-Cl, pH 7.4, 100 mM KCl, 0.2% Triton-X-100 and protease inhibitors) per gram of cells (wet weight). Lysates were cleared by centrifugation at 30 000 rpm in a TLA 100.3 in a Beckman TL-100 ultracentrifuge (Beckman Coulter). Lysate concentrations were approximately 10 mg protein/ml. HeLa cells were cultured in a similar manner with appropriate media and lysates were cleared by centrifugation at 13 000 g. RRL and wheat germ extracts were purchased from Promega. MALDI-TOF MS was performed by the Protein Chemistry Core Facility (Howard Hughes Medical Institute, Columbia University, New York, NY) after excision of protein bands from SDS-PAGE gels.
Cell Culture and etopical overexpression (transient transfection):
HeLa, RKO, and 293T cells were cultured in DMEM (10% FBS), and Hela S3 and MCF-7 cells in RPMI 1640 (10%FBS) in a waterjacket cell culture incubator with 5% CO 2 . Transient transfection was performed using Superfect reagent (Qiagen) as described by the manufacturer.
S protein labeling medium (metabolic labelling):
Dialysis of FBS overnight with PBS was performed prior to addition to RPMI 1640 at 10%. Labeling was performed with 0.15 mCi/ml [ 35 S]-Met and [ 35 S]-Cys).
Recombinant proteins:
The entire ORF of human eIF4AI was ligated in-frame into the BamHI and HindIII sites of the pET-28a expression vetor (EMD Biosciences, La Jolla, CA) after PCR amplification from HeLa cells. Protein was produced in BL21(DE3) E. coli cultured in LB medium by induction with 1 mM IPTG for 6 h at 37 °C. Cells were lysed by sonication in 50 mM phosphate, 300 mM NaCl, 1% Triton-X-100, pH 8.0 and protein was purified using Ni-NTA resin as described by the manufacturer. For pET(His 6 -eIF4B), induction conditions were for 72 h at 16 °C. Purification included a 1 ml Heparin column with a linear KCl gradient (50-500 mM).
ATPase Reactions:
All reaction components were mixed on ice and reactions were initiated by addition of RNA. 2 µl from each reaction were quenched by addition of 6 µl of a 2:1 solution of 90% Formamide and bromphenol blue: 300 mM EDTA. Indicated concentrations of cold ATP were supplemented with [γ-32 P]-ATP. Phosphate was separated from ATP by nondenaturing PAGE (TBE) on 15 cm 15% acrylamide gels.
Helicase Reactions: R-11 was radiolabeled using [γ-32 P]-ATP (6000 Ci/mmol) and T4 polynucleotide Kinase (New England Biolabs, Ipswich, MA) and purified using MicroSpin ™ G-25 Columns (GE Healthcare). Duplex RNA substrate was produced by annealing oligos R-11 and R-44 by incubation of equal molar amounts at 70 °C for 10 min followed by incubation at 37 °C for 1.5 h. R-11 sequence: 5′-gcuuuacggug-3′ R-44 sequence: 5′-gggagaaaaacaaaacaaaacaaaacuagcaccguaaagcacgc-3′
Reactions were quenched by addition of 5 µl quench buffer (50% glycerol, 2% SDS, 20 mM EDTA, and 0.05% bromphenol blue and xylene cyanol dyes). Duplex and single stranded RNA were separated by nondenaturing PAGE (TBE) on 20 cm 15% acrylamide gels. Gels were dried and autoradiography was performed. Quantitation was performed by aligning film with dried gels, excision of the bands, and scintillation counting. Figure S3 . Stimulation of ATP-dependent eIF4AI helicase activity by rabbit eIF4B is enhanced by DMDA-PatA. Helicase assay was performed as described for the E. coli recombinant 6XHis-4B described in the main text and in Figure 3H , with substitution of 6XHis-4B with the indicated concentration of eIF4B purified from rabbit reticlocyte lysate. Double stranded duplex, and single stranded RNA oligo are indicated by d and ss respectively. Reaction time was for 15 min at 37 °C.
Supplemental References
PatA DMSO eIF4B eIF4A 1 2 Figure S4 . Increased eIF4B-RNA interaction under PatA treatment. UVcrosslinking of protein factors from RRL with or without PatA treatment to radiolabeled β-globin RNA. eIF4A and eIF4B were identified by molecular weight. [α-32 P]-CTP (3000 Ci/mmol) labeled β-globin RNA was incubated for 15 min with RRL under DMSO or Pateamine A (40 uM) with 0.75 mM CHX at 30 °C. Protein-RNA complexes were fixed with UV light on ice using the UV Stratalinker Model 1800 (Stratagene) for 5 min then treated with 7.5 µg RNase A for 15 min at 37 °C. Samples were analyzed by SDS-PAGE and autoradiography. un-capped capped Figure S5 . Translation of capped β-globin RNA is more sensitive to Pateamine A than uncapped RNA. β-globin RNA was produced as capped or uncapped RNA and translation was performed in an in vitro RRL system using 200 ng of either RNA with DMSO, or indicated concentrations of PatA. Translation reactions were carried out in the Flexi ® Rabbit Reticulocyte Lysate system as described by the manufacturer (Promega) containing [
35 S]-methionine. Levels of translation were assessed by SDS-PAGE followed by gel drying and autoradiography.
The autoradiography for uncapped RNA was performed for 48 h, whereas the capped RNA data was collected following 24 h. , or GMPPNP were resolved by sucrose gradient centrifugation followed by fractionation and scintillation counting as described for β-globin RNA and EMCV RNA in Figure 5 and the main text. RNA was generated from vectors pcDNA-Luc (Yang et al., 2004) and pGEM4Cat-Luc. pcDNALuc was digested with BclI. pGEM4Cat-Luc is the pGEM4 vector (Promega) containing both CAT and Luciferase genes in a bicistronic arrangement translated from the T7 promoter. By digestion with NcoI, only the first cistron was translated from the T7 promoter. 5′-UTR sequences of the RNAs are (start codons are in lowercase):
pcDNA-Luc: 1) Binding of the 43S to "activated" mRNA, which is mediated by the eIF4F complex. This binding localizes both eIF4G, and eIF4A, which is bound to eIF4G, at the cap structure. eIF4F is believed to allow binding of the 43S complex through contacts between eIF4G and eIF3, and by removing local secondary structure on the RNA.
2) The bound 43S complex then "scans" along the UTR until an initiation codon (AUG) is located by the tRNA. Scanning requires ATP hydrolysis.
3) Once the AUG codon is located, the 43S becomes stably bound at that site.
4) Two molecules of GTP are hydrolyzed in facilitating release of initiation factors and joining of the 60S subunit.
Analysis of ribosome assembly in RRL using sucrose gradients suggests that step one, binding of the 43S complex to RNA was not affected by PatA (Fig. 5) . Co-treatments of PatA and CHX also demonstrated that PatA inhibited a step prior to 80S assembly. Co-treatments of PatA and GMPPNP (non-hydrolyzable GTP analogue) combined with toe-printing analysis suggested that PatA blocked a step prior to stable binding over the AUG codon. Thus, the data suggests that PatA blocks either step 2 or 3, as described in the scheme above. Also shown are schematic representations of PatA's effects on the eIF4F complex and eIF4A and eIF4B association.
